AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ORTHOCELL LTD

1.000

+0.0656.95%

Volume:551.19K

Turnover:538.98K

Market Cap:271.09M

PE:-26.06

High:1.000

Open:0.950

Low:0.940

Close:0.935

52wk High:1.700

52wk Low:0.855

Shares:271.09M

Float Shares:194.08M

Volume Ratio:1.55

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.038

EPS(LYR):-0.038

ROE:-89.70%

ROA:-26.42%

PB:18.61

PE(LYR):-26.06

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.74%

Capital Flow

Inflow:

Outflow:

News

Orthocell Eyes Fiscal 2027 Entry Into UK, European Union Markets

MT Newswires Live

BRIEF-Orthocell Posts Quarterly Revenue Of A$3.2 Million

Orthocell Finalizes Agreement With Biotechnology Company

MT Newswires Live

BRIEF-Orthocell Finalises Strategic Investment In Marine Biomedica

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/OCC.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OCC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","market":"AU","secType":"STK","nameCN":"ORTHOCELL LTD","latestPrice":1,"timestamp":1770700320000,"preClose":0.935,"halted":0,"volume":551191,"delay":0,"changeRate":0.06951871657754005,"nameEN":"ORTHOCELL LTD","floatShares":194076512,"shares":271090199,"eps":-0.03837,"marketStatus":"Not Yet Opened","change":0.065,"latestTime":"02-10 16:12:00 AEDT","open":0.95,"high":1,"low":0.94,"amount":538981,"amplitude":0.064171,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.03837,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.935,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.5467616807459772,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","floatShares":194076512,"roa":"-26.42%","roe":"-89.70%","lyrEps":-0.03837,"volumeRatio":1.5467616807459772,"shares":271090199,"dividePrice":0,"high":1,"amplitude":0.064171,"preClose":0.935,"low":0.94,"week52Low":0.855,"pbRate":"18.61","psRate":"35.90","week52High":1.7,"institutionHeld":0,"latestPrice":1,"eps":-0.03837,"divideRate":0,"volume":551191,"delay":0,"ttmEps":-0.03837,"open":0.95,"prevYearClose":1.085,"prevWeekClose":0.91,"prevMonthClose":0.92,"prevQuarterClose":1.085,"fiveDayClose":0.955,"twentyDayClose":1.06,"sixtyDayClose":1.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCC.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OCC.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608887369","title":"Orthocell Eyes Fiscal 2027 Entry Into UK, European Union Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2608887369","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608887369?lang=en_us&edition=fundamental","pubTime":"2026-02-02 07:51","pubTimestamp":1769989904,"startTime":"0","endTime":"0","summary":"Orthocell  said it plans to focus on completing launch planning for its fiscal 2027 entry into the UK and European Union markets, according to a Monday Australian bourse filing.Its total revenue for the first half of fiscal 2026 came in at AU$6.2 million, up from AU$4.2 million in the year-ago period.Orthocell estimated that it requires around 10,000 unit sales of its Remplir nerve repair product per annum in the US to reach cash breakeven, which is less than 1% of the addressable market, per the filing.The firm's shares rose 1% in early trading on Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","OCC.AU","BK7067"],"gpt_icon":0},{"id":"2604034649","title":"BRIEF-Orthocell Posts Quarterly Revenue Of A$3.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2604034649","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604034649?lang=en_us&edition=fundamental","pubTime":"2026-01-19 09:10","pubTimestamp":1768785047,"startTime":"0","endTime":"0","summary":"BRIEF-Orthocell Posts Quarterly Revenue Of A$3.2 MillionJan 19 (Reuters) - Orthocell Ltd OCC.AX:QTRLY REVENUE OF A$3.2 MILLIONFurther company coverage: OCC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YH1FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","OCC.AU","BK7508"],"gpt_icon":0},{"id":"2603955861","title":"Orthocell Finalizes Agreement With Biotechnology Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2603955861","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603955861?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:46","pubTimestamp":1768531607,"startTime":"0","endTime":"0","summary":"Orthocell  finalized an agreement with Marine Biomedical, increasing its equity interest to 11.7% from 1.72% for a total investment of AU$1.1 million, according to a Friday filing with the Australian bourse.The company also secured global distribution rights to PearlBone, Marine Biomedical's bone regeneration technology, as well as its future bone repair products under the deal, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","OCC.AU"],"gpt_icon":0},{"id":"2603951930","title":"BRIEF-Orthocell Finalises Strategic Investment In Marine Biomedica","url":"https://stock-news.laohu8.com/highlight/detail?id=2603951930","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603951930?lang=en_us&edition=fundamental","pubTime":"2026-01-16 09:24","pubTimestamp":1768526652,"startTime":"0","endTime":"0","summary":"BRIEF-Orthocell Finalises Strategic Investment In Marine BiomedicaJan 16  - Orthocell Ltd OCC.AX:ORTHOCELL FINALISES STRATEGIC INVESTMENT IN MARINE BIOMEDICACO INCREASED ITS EQUITY INTEREST IN MARINE BIOMEDICAL TO 11.7% FOR TOTAL INVESTMENT OF AU$1.05  MILLIONFurther company coverage: OCC.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YG0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCC.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":15,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OCC.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.017447}]}}